Alberta Azzi
Overview
Explore the profile of Alberta Azzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonizzoli M, Arvia R, di Valvasone S, Liotta F, Zakrzewska K, Azzi A, et al.
Med Microbiol Immunol
. 2016 May;
205(4):371-9.
PMID: 27138606
Acute respiratory distress syndrome (ARDS) is today a leading cause of hospitalization in intensive care unit (ICU). ARDS and pneumonia are closely related to critically ill patients; however, the etiologic...
2.
Arvia R, Corcioli F, Ciccone N, Della Malva N, Azzi A
Mol Cell Probes
. 2015 Sep;
29(6):408-413.
PMID: 26334289
Different viruses can be responsible for similar clinical manifestations of respiratory infections. Thus, the etiological diagnosis of respiratory viral diseases requires the detection of a large number of viruses. In...
3.
Rocca A, Martelli F, Delbue S, Ferrante P, Bartolozzi D, Azzi A, et al.
J Clin Virol
. 2015 Aug;
70:1-6.
PMID: 26305810
Background: In light of their regulatory role, changes in the expression of Polyomavirus JC (JCPyV) microRNAs may be relevant for virus reactivation and the development of progressive multifocal leukoencephalopathy (PML)....
4.
Martelli F, Salata C, Calistri A, Parolin C, Azzi A, Palu G, et al.
J Biotechnol
. 2015 Jun;
210:85-90.
PMID: 26091771
Human and avian influenza A viruses, associated with seasonal epidemics and occasionally with pandemics, have a high impact on public health. The development of new antivirals to counteract the emergence...
5.
Giovannelli I, Martelli F, Repice A, Massacesi L, Azzi A, Giannecchini S
J Neurovirol
. 2015 Feb;
21(6):666-70.
PMID: 25678142
Polyomavirus JC (JCPyV) reactivation and development of progressive multifocal leukoencephalopathy is a health concern in multiple sclerosis patients under natalizumab therapy. Here, the JCPyV microRNA-J1-3p and microRNA-J1-5p expressions and genomic...
6.
Clausi V, Giannecchini S, Magnani E, Repice A, Mechi C, Martelli F, et al.
Neurol Neuroimmunol Neuroinflamm
. 2015 Jan;
2(1):e58.
PMID: 25610882
Objective: To evaluate the frequency of JC polyomavirus (JCPyV) infection and anti-JCPyV antibodies in patients with multiple sclerosis under natalizumab therapy. Methods: Presence of anti-JCPyV antibodies and JCPyV DNA was...
7.
Arvia R, Corcioli F, Pierucci F, Azzi A
Viruses
. 2014 Nov;
6(11):4437-46.
PMID: 25412364
Co-circulation of two influenza B virus lineages, B/Yamagata and B/Victoria, has been recognized since the late 1980s. The assessment of the prevalent lineage and the group of viruses in circulation...
8.
Peris A, Zagli G, Bernardo P, Bonacchi M, Cozzolino M, Perretta L, et al.
Case Rep Med
. 2014 Feb;
2014:560208.
PMID: 24527039
Pandemic influenza virus A(H1N1) 2009 was associated with a higher risk of viral pneumonia in comparison with seasonal influenza viruses. The influenza season 2011-2012 was characterized by the prevalent circulation...
9.
Stincarelli M, Arvia R, De Marco M, Clausi V, Corcioli F, Cotti C, et al.
Virus Res
. 2013 May;
175(2):151-4.
PMID: 23639426
Exploring the reassortment ability of the 2009 pandemic H1N1 (A/H1N1pdm09) influenza virus with other circulating human or avian influenza viruses is the main concern related to the generation of more...
10.
Arvia R, Corcioli F, Azzi A
J Virol Methods
. 2013 Mar;
189(2):265-70.
PMID: 23499313
A real-time PCR followed by high resolution melting analysis (HRMA) was developed, for rapid detection of antiviral resistance markers in influenza A viruses, of both H1N1 and H3N2 subtypes. The...